Is Low-Dose Daily Cialis/Tadalafil Effective in Treating Erectile Dysfunction/ED?

Cialis > cialis tadalafil 5 mg 28 tablets


In addition, there was no evidence of teratogenicity, embryotoxicity, or fetotoxicity when tadalafil was given to pregnant rats or mice at exposures up to 11 times the MRHD during the period of major organ development. In a rat prenatal and postnatal development study at doses of 60, 200, and 1000 mg/kg, a reduction in postnatal survival of pups was observed. This gives approximately 16 and 10 fold exposure multiples, respectively, of the human AUC for the MRHD of 20 mg. Tadalafil and/or its metabolites cross the placenta, resulting in fetal exposure in rats.

5.12 Effects on Bleeding

Food and alcohol intake were not restricted.Several assessment tools were used to evaluate the effect of CIALIS on erectile function. The 3 primary outcome measures were the Erectile Function (EF) domain of the International Index of Erectile Function (IIEF) and Questions 2 and 3 from Sexual Encounter Profile (SEP). The IIEF is a 4-week recall questionnaire that was administered at the end of a treatment-free baseline period and subsequently at follow-up visits after randomization. The IIEF EF domain has a 30-point total score, where higher scores reflect better erectile function. SEP is a diary in which patients recorded each sexual attempt made throughout the study.

Stimulation increases blood flow

SEP Question 2 asks, “Were you able to insert your penis into the partner's vagina?” SEP Question 3 asks, “Did your erection last long enough for you to have successful intercourse?” The overall percentage of successful attempts to insert the penis into the vagina (SEP2) and to maintain the erection for successful intercourse (SEP3) is derived for each patient.Results in ED Population in US Trials — The 2 primary US efficacy and safety trials included a total of 402 men with erectile dysfunction, with a mean age of 59 years (range 27 to 87 years). The population was 78% White, 14% Black, 7% Hispanic, and 1% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (>90%) patients reported ED of at lilly cialis least 1-year duration. Study A was conducted primarily in academic centers. Study B was conducted primarily in community-based urology practices. Tadalafil and/or its metabolites were secreted into the milk in lactating rats at concentrations approximately 2.4-fold greater than found in the plasma.

Product Dosage Quantity + Bonus Price
Cialis Professional20mg20 Pills78.33€ 74.60€
Cialis Generic2.5mg180 + 10 Pills154.86€ 147.49€
Cialis Generic60mg60 + 4 Pills145.06€ 138.15€
Cialis Professional20mg90 + 2 Pills241.49€ 229.99€
Cialis Super Active20mg10 Pills55.64€ 52.99€
Cialis Super Active20mg270 + 30 Pills661.49€ 629.99€
Cialis Soft Tabs20mg270 + 10 Pills471.40€ 448.95€
Cialis Generic40mg120 + 8 Pills206.98€ 197.12€
Cialis Generic10mg360 + 10 Pills388.49€ 369.99€
Cialis Soft Tabs20mg60 + 4 Pills159.37€ 151.78€
Cialis Professional20mg30 Pills104.57€ 99.59€

14 CLINICAL STUDIES 14.1 CIALIS for Use as NeededThe efficacy and safety of tadalafil in the treatment of erectile dysfunction has been evaluated in 22 clinical trials of up to 24-weeks duration, involving over 4000 patients.

Product Overview

In addition, there was no evidence of teratogenicity, embryotoxicity, or fetotoxicity when tadalafil was given to pregnant rats or mice at exposures up to 11 times the MRHD during the period of major organ development. In a rat prenatal and postnatal development study at doses of 60, 200, and 1000 mg/kg, a reduction in postnatal survival of pups was observed. This gives approximately 16 and 10 fold exposure multiples, respectively, of the human AUC for the MRHD of 20 mg. Tadalafil and/or its metabolites cross the placenta, resulting in fetal exposure in rats. Tadalafil and/or its metabolites were secreted into the milk in lactating rats at concentrations approximately 2.4-fold greater than found in the plasma.

Comparison with actions of other PDE5 inhibitors

14 CLINICAL STUDIES 14.1 CIALIS for Use as NeededThe efficacy and safety of tadalafil in the treatment of erectile dysfunction has been evaluated in 22 clinical trials of up to 24-weeks duration, involving over 4000 patients. CIALIS, when taken as needed up to once per day, was shown to be effective in improving erectile function in men with erectile dysfunction (ED).CIALIS was studied in the general ED population in 7 randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design, primary efficacy and safety studies of 12-weeks duration. Two of these studies were conducted in the United States and 5 were conducted in centers outside the US. Additional efficacy and safety studies were performed in ED patients with diabetes mellitus and in patients who developed ED status post bilateral nerve-sparing radical prostatectomy.In these 7 trials, CIALIS was taken as needed, at doses ranging from 2.5 to 20 mg, up to once per day. Patients were free to choose the time interval between dose administration and the time of sexual attempts. CIALIS, when taken as needed up to once per day, was shown to be effective in improving erectile function in men with erectile dysfunction (ED).CIALIS was studied in the general ED population in 7 randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design, primary efficacy and safety studies of 12-weeks duration.

Retailer Type Price Range for 28 Tablets Prescriptions Required Online Purchase Availability
Local Pharmacies $30 – $50 Yes Yes
Online Pharmacies $25 – $45 Yes Yes
Discount Stores $20 – $40 Yes Limited

Two of these studies were conducted in the United States and 5 were conducted in centers outside the US. Additional efficacy and safety studies were performed in ED patients with diabetes mellitus and in patients who developed ED status post bilateral nerve-sparing radical prostatectomy.In these 7 trials, CIALIS was taken as needed, at doses ranging from 2.5 to 20 mg, up to once per day. Patients were free to choose the time interval between dose administration and the time of sexual attempts. Food and alcohol intake were not restricted.Several assessment tools were used to evaluate the effect of CIALIS on erectile function. The 3 primary outcome measures were the Erectile Function (EF) domain of the International Index of Erectile Function (IIEF) and Questions 2 and 3 from Sexual Encounter Profile (SEP). The IIEF is a 4-week recall questionnaire that was administered at the end of a treatment-free baseline period and subsequently at follow-up visits after randomization. The IIEF EF domain has a 30-point total score, where higher scores reflect better erectile function. SEP is a diary in which patients recorded each sexual attempt made throughout the study. SEP Question 2 asks, “Were you able to insert your penis into the partner's vagina?” SEP Question 3 asks, “Did your erection last long enough for you to have successful intercourse?” The overall percentage of successful attempts to insert the penis into the vagina (SEP2) and to maintain the erection for successful intercourse (SEP3) is derived for each patient.Results in ED Population in US Trials — The 2 primary US efficacy and safety trials included a total of 402 men with erectile dysfunction, with a mean age of 59 years (range 27 to 87 years). The population was 78% White, 14% Black, 7% Hispanic, and 1% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (>90%) patients reported ED of at lilly cialis least 1-year duration. Study A was conducted primarily in academic centers. Study B was conducted primarily in community-based urology practices.

17.4 Potential for Drug Interactions When Taking CIALIS for Once Daily Use

In this randomized, placebo-controlled, double-blinded trial, 223 patients were randomized to placebo, CIALIS 10, or 20 mg. Using a stopwatch, patients recorded the time following dosing at which a successful erection was obtained. A successful erection was defined as at least 1 erection in 4 attempts that led to successful intercourse. At or prior to 30 minutes, 35% (26/74), 38% (28/74), and 52% (39/75) of patients in the placebo, 10-, and 20-mg groups, respectively, reported successful erections as defined above.Two studies were conducted to assess the efficacy of CIALIS at a given timepoint after dosing, specifically at 24 hours and at 36 hours after dosing.In the first of these studies, 348 patients with ED were randomized to placebo or CIALIS 20 mg. Patients were encouraged to make 4 total attempts at intercourse; 2 attempts were to occur at 24 hours after dosing and 2 completely separate attempts were to occur at 36 hours after dosing.

Before taking tadalafil,

The results demonstrated a difference between the placebo group and the cialis 20 mg 8 tablets CIALIS group at each of the pre-specified timepoints. At the 24-hour timepoint, (more specifically, 22 to 26 hours), 53/144 (37%) patients reported at least 1 successful intercourse in the placebo group versus 84/138 (61%) in the CIALIS 20-mg group. At the 36-hour timepoint (more specifically, 33 to 39 hours), 49/133 (37%) of patients reported at least 1 successful intercourse in the placebo group versus 88/137 (64%) in the CIALIS 20-mg group.In the second of these studies, a total of 483 patients were evenly randomized to 1 of 6 groups: 3 different dosing groups (placebo, CIALIS 10, or 20 mg) that were instructed to attempt intercourse at 2 different times (24 and 36 hours post-dosing). Patients were encouraged to make 4 separate attempts at their assigned dose and assigned timepoint. In this study, the results demonstrated a statistically significant difference between the placebo group and the CIALIS groups at each of the pre-specified timepoints. In each of these 2 trials, CIALIS 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables (see Table 10). The treatment effect of CIALIS did not diminish over time.Results in General ED Population in Trials Outside the US — The 5 primary efficacy and safety studies conducted in the general ED population outside the US included 1112 patients, with a mean age of 59 years (range 21 to 82 years). The population was 76% White, 1% Black, 3% Hispanic, and 20% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (90%) patients reported ED of at least 1-year duration.

  • The 28-tablet pack offers a 4-week supply for daily dosing.
  • Cialis Tadalafil 5 mg is known for its fast absorption within 30 minutes.
  • It is recommended to take Cialis Tadalafil 5 mg at the same time daily.
  • The medication helps maintain an erection for satisfying intimacy.
  • Cialis Tadalafil 5 mg may cause muscle aches or back pain in some users.
  • Never double dose if you miss a dose of Cialis Tadalafil 5 mg.
  • Consult your doctor if you experience prolonged erections over 4 hours.
  • Cialis Tadalafil 5 mg is approved by health authorities for ED treatment.
  • The medication can be used with or without food.
  • Use Cialis Tadalafil 5 mg responsibly to avoid dependence.
  • Always review the prescribing information before starting Cialis Tadalafil 5 mg.

In these 5 trials, CIALIS 5, 10, and 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables (see Tables 11, 12 and 13).

Patient Group Recommended Dose Frequency Special Instructions
Adults with ED 5 mg Once daily as needed Take 30 mins before activity
Elderly Patients 5 mg As prescribed Be cautious of interactions
Patients with Liver Adjusted dose as per doctor Once daily Consult physician

The treatment effect of CIALIS did not diminish over time.In addition, there were improvements in EF domain scores, success rates based upon SEP Questions 2 and 3, and patient-reported improvement in erections across patients with ED of all degrees of disease severity while taking CIALIS, compared to patients on placebo.Therefore, in all 7 primary efficacy and safety studies, CIALIS showed statistically significant improvement in patients' ability to achieve an erection sufficient for vaginal penetration and to maintain the erection long enough for successful intercourse, as measured by the IIEF questionnaire and by SEP diaries.Efficacy Results in ED Patients with Diabetes Mellitus — CIALIS was shown to be effective in treating ED in patients with diabetes mellitus. Patients with diabetes were included in all 7 primary efficacy studies in the general ED population (N=235) and in one study that specifically assessed CIALIS in ED patients with type 1 or type 2 diabetes (N=216). In this randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial, CIALIS demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 14).Efficacy Results in ED Patients following Radical Prostatectomy — CIALIS was shown to be effective in treating patients who developed ED following bilateral nerve-sparing radical prostatectomy.

2.2 Use with Food

At the 24-hour timepoint, the mean, per patient percentage of attempts resulting in successful intercourse were 42, 56, and 67% for the placebo, CIALIS 10-, and 20-mg groups, respectively. At the 36-hour timepoint, the mean, per-patient percentage of attempts resulting in successful intercourse were 33, 56, and 62% for placebo, CIALIS 10-, and 20-mg groups, respectively.14.2 CIALIS for Once Daily UseThe efficacy and safety of CIALIS for once daily use in the treatment of erectile dysfunction has been evaluated in 2 clinical trials of 12-weeks duration and 1 clinical trial of 24-weeks duration, involving a total of 853 patients. CIALIS, when taken once daily, was shown to be effective in improving erectile function in men with erectile dysfunction (ED).CIALIS was studied in the general ED population in 2 randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design, primary efficacy and safety studies of 12- and 24-weeks duration, respectively. One of these studies was conducted in the United States and one was conducted in centers outside the US. An additional efficacy and safety study was performed in ED patients with diabetes mellitus. In 1 randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial in this population (N=303), CIALIS demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 15).Results in Studies to Determine the Optimal Use of CIALIS — Several studies were conducted with the objective of determining the optimal use of CIALIS in the treatment of ED. In one of these studies, the percentage of patients reporting successful erections within 30 minutes of dosing was determined.

  • Cialis Tadalafil 5 mg can be obtained with a valid prescription.
  • The tablets are designed for oral administration once daily.
  • It is essential not to combine with recreational drugs.
  • The medication is suitable for men with various health backgrounds.
  • Be aware of potential side effects, including dizziness and upset stomach.
  • Consult your doctor about any ongoing medical conditions.
  • The long duration of action makes it different from other ED drugs.
  • Use of Cialis Tadalafil 5 mg enhances sexual performance confidence.
  • Avoid operating machinery after taking this medication.
  • The medication should be combined with open communication with your partner.
  • Ensure dosage instructions are followed strictly for safety.

In this randomized, placebo-controlled, double-blinded trial, 223 patients were randomized to placebo, CIALIS 10, or 20 mg. Using a stopwatch, patients recorded the time following dosing at which a successful erection was obtained. A successful erection was defined as at least 1 erection in 4 attempts that led to successful intercourse.

  • Cialis Tadalafil 5 mg is a daily pill for ongoing erectile dysfunction control.
  • The medication helps achieve spontaneous sexual activity.
  • The dosage may be adjusted based on individual response and tolerance.
  • Cialis Tadalafil 5 mg does not cause long-term dependency.
  • It is important to adhere to your prescribed dose for safety.
  • Cialis Tadalafil 5 mg is a trusted medication in ED treatment.
  • Combining with a healthy diet enhances overall benefits.
  • Do not take more than one dose per 24 hours.
  • If you experience chest pain, seek emergency medical help.
  • Patients should inform their doctor of any prior medication reactions.
  • The pill's efficacy is backed by clinical trials and research.

At or prior to 30 minutes, 35% (26/74), 38% (28/74), and 52% (39/75) of patients in the placebo, 10-, and 20-mg groups, respectively, reported successful erections as defined above.Two studies were conducted to assess the efficacy of CIALIS at a given timepoint after dosing, specifically at 24 hours and at 36 hours after dosing.In the first of these studies, 348 patients with ED were randomized to placebo or CIALIS 20 mg.

  • Patients should inform their doctor about all medications before starting Cialis Tadalafil 5 mg.
  • Cialis Tadalafil 5 mg helps improve intimacy and confidence.
  • Excessive alcohol worsens the risk of side effects with Cialis Tadalafil 5 mg.
  • Do not crush or break the tablets; take them whole.
  • Cialis Tadalafil 5 mg is safe for most men when used as directed.
  • Some users report mild dizziness after taking Cialis Tadalafil 5 mg.
  • The medication’s duration allows for flexible planning of intimacy.
  • This drug should not be used in combination with other ED treatments.
  • Persistent pain or side effects require medical consultation.
  • Proper hydration and a healthy lifestyle enhance efficacy.
  • Cialis Tadalafil 5 mg is suitable for men age 18 and above.

Patients were encouraged to make 4 total attempts at intercourse; 2 attempts were to occur at 24 hours after dosing and 2 completely separate attempts were to occur at 36 hours after dosing. The results demonstrated a difference between the placebo group and the cialis 20 mg 8 tablets CIALIS group at each of the pre-specified timepoints. At the 24-hour timepoint, (more specifically, 22 to 26 hours), 53/144 (37%) patients reported at least 1 successful intercourse in the placebo group versus 84/138 (61%) in the CIALIS 20-mg group. At the 36-hour timepoint (more specifically, 33 to 39 hours), 49/133 (37%) of patients reported at least 1 successful intercourse in the placebo group versus 88/137 (64%) in the CIALIS 20-mg group.In the second of these studies, a total of 483 patients were evenly randomized to 1 of 6 groups: 3 different dosing groups (placebo, CIALIS 10, or 20 mg) that were instructed to attempt intercourse at 2 different times (24 and 36 hours post-dosing). Patients were encouraged to make 4 separate attempts at their assigned dose and assigned timepoint. In this study, the results demonstrated a statistically significant difference between the placebo group and the CIALIS groups at each of the pre-specified timepoints. At the 24-hour timepoint, the mean, per patient percentage of attempts resulting in successful intercourse were 42, 56, and 67% for the placebo, CIALIS 10-, and 20-mg groups, respectively.

Discreet Packaging

CIALIS was taken once daily at doses ranging from 2.5 to 10 mg. Food and alcohol intake were not restricted. Timing of sexual activity was not restricted relative to when patients took Cialis.Results in General ED Population — The primary US efficacy and safety trial included a total of 287 patients, with a mean age of 59 years (range 25 to 82 years). At the 36-hour timepoint, the mean, per-patient percentage of attempts resulting in successful intercourse were 33, 56, and 62% for placebo, CIALIS 10-, and 20-mg groups, respectively.14.2 CIALIS for Once Daily UseThe efficacy and safety of CIALIS for once daily use in the treatment of erectile dysfunction has been evaluated in 2 clinical trials of 12-weeks duration and 1 clinical trial of 24-weeks duration, involving a total of 853 patients. CIALIS, when taken once daily, was shown to be effective in improving erectile function in men with erectile dysfunction (ED).CIALIS was studied in the general ED population in 2 randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design, primary efficacy and safety studies of 12- and 24-weeks duration, respectively. One of these studies was conducted in the United States and one was conducted in centers outside the US. An additional efficacy and safety study was performed in ED patients with diabetes mellitus.

How should this medicine be used?

In each of these 2 trials, CIALIS 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables (see Table 10). The treatment effect of CIALIS did not diminish over time.Results in General ED Population in Trials Outside the US — The 5 primary efficacy and safety studies conducted in the general ED population outside the US included 1112 patients, with a mean age of 59 years (range 21 to 82 years). The population was 76% White, 1% Black, 3% Hispanic, and 20% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (90%) patients reported ED of at least 1-year duration. In these 5 trials, CIALIS 5, 10, and 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables (see Tables 11, 12 and 13).

Muscular Dystrophy (Orphan)

The treatment effect of CIALIS did not diminish over time.In addition, there were improvements in EF domain scores, success rates based upon SEP Questions 2 and 3, and patient-reported improvement in erections across patients with ED of all degrees of disease severity while taking CIALIS, compared to patients on placebo.Therefore, in all 7 primary efficacy and safety studies, CIALIS showed statistically significant improvement in patients' ability to achieve an erection sufficient for vaginal penetration and to maintain the erection long enough for successful intercourse, as measured by the IIEF questionnaire and by SEP diaries.Efficacy Results in ED Patients with Diabetes Mellitus — CIALIS was shown to be effective in treating ED in patients with diabetes mellitus. Patients with diabetes were included in all 7 primary efficacy studies in the general ED population (N=235) and in one study that specifically assessed CIALIS in ED patients with type 1 or type 2 diabetes (N=216). In this randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial, CIALIS demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 14).Efficacy Results in ED Patients following Radical Prostatectomy — CIALIS was shown to be effective in treating patients who developed ED following bilateral nerve-sparing radical prostatectomy. In 1 randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial in this population (N=303), CIALIS demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 15).Results in Studies to Determine the Optimal Use of CIALIS — Several studies were conducted with the objective of determining the optimal use of CIALIS in the treatment of ED. In one of these studies, the percentage of patients reporting successful erections within 30 minutes of dosing was determined. CIALIS was taken once daily at doses ranging from 2.5 to 10 mg. Food and alcohol intake were not restricted. Timing of sexual activity was not restricted relative to when patients took Cialis.Results in General ED Population — The primary US efficacy and safety trial included a total of 287 patients, with a mean age of 59 years (range 25 to 82 years).

Rahel Stoll

Seit der Kindheit wünschte ich in einem helfenden, die Menschen begleitenden Beruf tätig zu sein. Schon früh in meiner ärztlichen Ausbildung an der Universität Zürich mit Staatsexamen 1985 begeisterte mich das Fach Gynäkologie und Geburtshilfe. So schrieb ich bereits während dem Medizinstudium meine Dissertation in diesem Bereich und promovierte am 1.1.1986. Meine Ausbildung an diversen Kliniken führte mich zur Fachärztin für Allgemeine Innere Medizin FMH im Jahre 1994. In den folgenden Jahren war ich zuerst teilweise, dann ausschliesslich in der Gynäkologie und Geburtshilfe tätig nebst meiner schönsten Aufgabe des Mutterseins von  drei mittlerweilen erwachsenen Kindern. Im 2002 liess mich eine liebe Kollegin in ihrer Praxis in Zürich Oerlikon als selbstständige Frauenärztin tätig sein. Nach stetigem Patientinnenzuwachs konnte ich später die Frauenarztpraxis in Opfikon eigenständig übernehmen. Viele Jahre war und ist mir die Begleitung «meiner Frauen» in und ausserhalb der Schwangerschaft eine grosse Freude und Erfüllung. Dankbar für ihr langjähriges Vertrauen habe ich nun das Glück, meine Praxis per 1. Juli 2022 in jüngere, kompetente und liebevolle Hände zu übergeben und gleichzeitig  weiterhin Patientinnen mitbegleiten zu dürfen.

Ich freue mich auf Sie.

Benjamin Rudolf

LEBENSLAUF

1997 - 2004 Studium der Medizin an der Universität zu Köln /D
2004 - 2009 Ausbildung zum Facharzt für Gynäkologie und Geburtshilfe

• Vinzenz-Pallotti-Hospital Bensberg/D
• St.-Marien-Hospital am Venusberg Bonn/D
• St. Johannes-Krankenhaus Troisdorf/D
2009 Facharzttitel
2009 - 2011 Oberarzt für Gynäkologie und Geburtshilfe im St. Johannes Krankenhaus Troisdorf/D
2011 - 2014 Oberarzt für Gynäkologie und Geburtshilfe im Spital Bülach/CH
2014-2022 Leitender Arzt der Abteilung für Gynäkologie und Geburtshilfe im Spital Bülach/CH
Seit August 2022 Selbstständiger Facharzt in der GynPraxis Opfikon

Qualifikationen